Polyclonal Antibodies Against Equine Rhinitis A Virus 3AB, 3C and 3D Proteins
Technology description
Description
Equine rhinitis A virus, formerly known as equine rhinovirus 1, causes a respiratory disease in horses similar to the common cold in humans. No vaccines against this virus are available commercially and no specific antiviral treatment exists. UW-Madison researchers have developed polyclonal antibodies against recombinant proteins from equine rhinitis A virus. The antibodies can be used for specific molecular recognition of the equine rhinitis A virus proteins in vitro or in vivo using experimental techniques such as ELISA (enzyme linked immunosorbent assay), Western assays, protein immunoprecipitation (IP) and confocal fluorescence microscopy.